T1	Participants 709 769	variceal rebleeding and patient survival at 1-year follow-up
T2	Participants 771 982	Treatment groups were similar in incidence of variceal rebleeding (41.9% vs. 42.9%), variceal obliteration (41.9% vs. 40.0%), hospital days, blood transfusions, shunt requirements, and survival (71.0% vs. 60.0%)
